1 in 3 women and 1 in 5 men in Canada will suffer an osteoporotic fracture in their lifetime. Reduce your risk by attending an Osteoporosis Screening Clinic at London Drugs.
Affecting both men and women, and with no one single cause, pharmacists say Osteoporosis is a condition that more people should undergo screening for. Approximately two million Canadians each year are affected by osteoporosis, which leads to an increased risk of fractures, often in the wrist, spine, shoulder, and hip. One in three women and one in five men will suffer an osteoporotic fracture in their lifetime.
Fractures can lead to chronic pain, disability, loss of independence, and even death. There are usually no symptoms of osteoporosis until a broken bone occurs, but if caught early through screening, patients can prevent further bone loss and avoid potential falls and fractures.
Osteoporosis Screening Clinics held at London Drugs provide convenient access to routine screening at the pharmacy. Using the World Health Organization’s FRAX assessment tool and Sunlight Omnisense® device, pharmacists scan and measure patient’s bone strength of the wrist and assess their risk for falls and fractures.
Post-screening, patients are given an assessment of their vitamin D and calcium intake, lifestyle factors, and existing medical conditions as they relate to fracture risk. Each patient is then provided with tips on how to minimize their risks, and a personalized action plan to fit their wellness goals. The complete consultation takes about 45-minutes.
Pharmacists now play an important role in osteoporosis prevention education, helping Canadians understand their risk of developing Osteoporosis, before a fracture occurs. In fact, community pharmacist-initiated screening programs double the number of patients tested and treated for osteoporosis.
To learn more, view the Osteoporosis Screening Clinic schedule to book an appointment online, or call the pharmacy.